82 related articles for article (PubMed ID: 20418189)
21. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes.
Bleeker FE; Lamba S; Rodolfo M; Scarpa A; Leenstra S; Vandertop WP; Bardelli A
Hum Mutat; 2009 Feb; 30(2):E451-9. PubMed ID: 19058223
[TBL] [Abstract][Full Text] [Related]
22. Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes.
Papavasiliou FN; Schatz DG
Nature; 2000 Nov; 408(6809):216-21. PubMed ID: 11089977
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin kappa gene repertoire and somatic hypermutation patterns in follicular lymphoma.
Smilevska T; Tsakou E; Hadzidimitriou A; Bikos V; Stavroyianni N; Laoutaris N; Fassas A; Alphanagnostopoulos A; Papadaki T; Belessi C; Stamatopoulos K
Blood Cells Mol Dis; 2008; 41(2):215-8. PubMed ID: 18640859
[TBL] [Abstract][Full Text] [Related]
24. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.
Martin A; Bardwell PD; Woo CJ; Fan M; Shulman MJ; Scharff MD
Nature; 2002 Feb; 415(6873):802-6. PubMed ID: 11823785
[TBL] [Abstract][Full Text] [Related]
25. A reporter gene to analyse the hypermutation of immunoglobulin genes.
Chui YL; Lozano F; Jarvis JM; Pannell R; Milstein C
J Mol Biol; 1995 Jun; 249(3):555-63. PubMed ID: 7783211
[TBL] [Abstract][Full Text] [Related]
26. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase.
McBride KM; Barreto V; Ramiro AR; Stavropoulos P; Nussenzweig MC
J Exp Med; 2004 May; 199(9):1235-44. PubMed ID: 15117971
[TBL] [Abstract][Full Text] [Related]
27. Antigen-induced somatic diversification of rabbit IgH genes: gene conversion and point mutation.
Winstead CR; Zhai SK; Sethupathi P; Knight KL
J Immunol; 1999 Jun; 162(11):6602-12. PubMed ID: 10352277
[TBL] [Abstract][Full Text] [Related]
28. Double-strand breaks in DNA during somatic hypermutation of Ig genes: cause or consequence?
Rogozin IB; Kunkel TA; Pavlov YI
Trends Immunol; 2002 Jan; 23(1):12-3. PubMed ID: 11801448
[No Abstract] [Full Text] [Related]
29. Mutagenesis by Microbe: the Role of the Microbiota in Shaping the Cancer Genome.
Barrett M; Hand CK; Shanahan F; Murphy T; O'Toole PW
Trends Cancer; 2020 Apr; 6(4):277-287. PubMed ID: 32209443
[TBL] [Abstract][Full Text] [Related]
30. Hypermutation in human cancer genomes: footprints and mechanisms.
Roberts SA; Gordenin DA
Nat Rev Cancer; 2014 Dec; 14(12):786-800. PubMed ID: 25568919
[TBL] [Abstract][Full Text] [Related]
31. Somatic hypermutation is a matter of choice.
Bolland D; Corcoran A
Nat Immunol; 2007 Jul; 8(7):677-9. PubMed ID: 17579643
[No Abstract] [Full Text] [Related]
32. The Impact of Environmental and Endogenous Damage on Somatic Mutation Load in Human Skin Fibroblasts.
Saini N; Roberts SA; Klimczak LJ; Chan K; Grimm SA; Dai S; Fargo DC; Boyer JC; Kaufmann WK; Taylor JA; Lee E; Cortes-Ciriano I; Park PJ; Schurman SH; Malc EP; Mieczkowski PA; Gordenin DA
PLoS Genet; 2016 Oct; 12(10):e1006385. PubMed ID: 27788131
[TBL] [Abstract][Full Text] [Related]
33. Both DNA strands of antibody genes are hypermutation targets.
Milstein C; Neuberger MS; Staden R
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8791-4. PubMed ID: 9671757
[TBL] [Abstract][Full Text] [Related]
34. Pillars Article: Origin of antibody variation. Nature 1966. 211: 242-243.
Brenner S; Milstein C
J Immunol; 2006 Oct; 177(7):4237-8. PubMed ID: 16982853
[No Abstract] [Full Text] [Related]
35. The ages of the cancer-associated genes.
Stein WD
Semin Oncol; 2019 Feb; 46(1):10-18. PubMed ID: 30554805
[TBL] [Abstract][Full Text] [Related]
36. Counterpoints in cancer: the somatic mutation theory under attack.
Thomas D; Moore A
Bioessays; 2011 May; 33(5):313-4. PubMed ID: 21503932
[No Abstract] [Full Text] [Related]
37. Liquid biopsies reveal the dynamic nature of resistance mechanisms in solid tumors.
Meador CB; Lovly CM
Nat Med; 2015 Jul; 21(7):663-5. PubMed ID: 26151324
[No Abstract] [Full Text] [Related]
38. Somatic Mutation Events Were Characterized Across the Whole Cancer Genome.
Cancer Discov; 2022 Jun; 12(6):1409. PubMed ID: 35452073
[TBL] [Abstract][Full Text] [Related]
39. Preventing prejudice in genome profiling.
Maruthappu M; Finlayson AE
Science; 2013 Apr; 340(6130):273. PubMed ID: 23599461
[No Abstract] [Full Text] [Related]
40. Antibody wars: extreme diversity.
Gearhart PJ
J Immunol; 2006 Oct; 177(7):4235-6. PubMed ID: 16982852
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
